Immunoglobulin lambda variable 3-24 (IGLV3-24)

Immunoglobulin lambda variable 3-24 (IGLV3-24) is classified as a pseudogene, which means it is a non-functional DNA sequence in the immunoglobulin lambda light chain variable region gene family[1][8]. Pseudogenes like IGLV3-24 do not give rise to functional protein products and, as such, are not direct therapeutic targets or involved in known physiological signaling pathways. The immunoglobulin lambda locus contains both functional variable region genes and multiple pseudogenes, resulting from gene duplication and evolutionary processes[5]. While some immunoglobulin lambda variable region genes are involved in antigen binding as part of antibodies, IGLV3-24 itself does not contribute functionally to immune response, disease mechanisms, or the repertoire of therapeutic targets[8]. There are no known drugs, biomarkers, or mechanisms of action linked specifically to IGLV3-24. Additional context: - The immunoglobulin lambda gene family as a whole plays key roles in the adaptive immune response, but only the functional gene members encode variable regions for antigen recognition[3][7]. - Pseudogenes may sometimes be referenced in disease association studies or as markers but do not confer function themselves. - According to major gene annotation databases and scientific suppliers, IGLV3-24 is consistently denoted as a pseudogene, not a coding (functional) gene[1][8]. Summary guidance: There is nothing directly functional or therapeutically actionable about IGLV3-24; it is not considered a therapeutic target, receptor, enzyme, or otherwise druggable molecule. This entry may be an error or reflect a misunderstanding if the intention was to identify a functional target.

Other names

Immunoglobulin lambda variable 3-24 (pseudogene)